{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T14:33:25Z","timestamp":1771338805565,"version":"3.50.1"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Splenic hemangiosarcoma (SHSA) is an aggressive neoplasm of dogs characterized by high metastatic rate and short survival time. Although staging and treatment are well established prognostic factors, the implication of specific metastatic sites remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis\/Objectives<\/jats:title>\n                    <jats:p>Describe the frequency and distribution of metastatic site at diagnosis in dogs with SHSA and evaluate the potential prognostic role of different metastatic locations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Sixty-six dogs with histologically confirmed SHSA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective, multicenter, descriptive study of dogs with SHSA treated by splenectomy. Data collected included demographics, clinical stage, and site of metastasis at diagnosis and at death, staging procedures, histopathology results, treatment protocols, and outcome. Survival analysis was conducted using Kaplan-Meier and Cox proportional hazards models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At diagnosis, three dogs were stage I (5%), 35 stage II (53%), and 28 stage III (42%). Overall median tumor-specific survival (TSS) was 132\u00a0days. Stage III disease and hepatic metastases were associated with significantly decreased survival (P\u00a0&amp;lt;\u00a0.001). Dogs with liver metastasis that received anthracycline-based chemotherapy had longer survival compared with dogs that received metronomic therapy (255 vs 65\u00a0days, P\u00a0=\u00a0.02). Muscular and pulmonary metastases did not correlate with worse outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and clinical importance<\/jats:title>\n                    <jats:p>Stage and treatment were confirmed as prognostic factors, with patients in stage III and patients having received surgery alone having a worse prognosis. Although current staging classifies all metastatic disease as stage III, metastatic site may have variable impact on survival and should be considered when devising treatment strategy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jvimsj\/aalag027","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T13:59:33Z","timestamp":1771336773000},"source":"Crossref","is-referenced-by-count":0,"title":["Frequency, distribution, and prognostic impact of metastatic site in dogs with splenic hemangiosarcoma"],"prefix":"10.1093","volume":"40","author":[{"given":"Paola","family":"Valenti","sequence":"first","affiliation":[{"name":"Clinica Veterinaria Malpensa AniCura , Samarate 21017 ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Bacci","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medical Sciences (DIMEVET), University of Bologna , Ozzano dell\u2019Emilia 40064 ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Catalucci","sequence":"additional","affiliation":[{"name":"Clinica Veterinaria Malpensa AniCura , Samarate 21017 ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Treggiari","sequence":"additional","affiliation":[{"name":"Oncopets Veterinary Centre , Milan 20142 ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco Luigi","family":"Bianchi","sequence":"additional","affiliation":[{"name":"DocVet , Nerviano 20014 ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Capra","sequence":"additional","affiliation":[{"name":"Clinica Veterinaria Malpensa AniCura , Samarate 21017 ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Avallone","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medical Sciences (DIMEVET), University of Bologna , Ozzano dell\u2019Emilia 40064 ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"2026021708592730400_ref1","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.exphem.2006.04.013","article-title":"Canine hemangiosarcoma originates from hematopoietic precursors with potential for endothelial differentiation","volume":"34","author":"Lamerato-Kozicki","year":"2006","journal-title":"Exp Hematol"},{"key":"2026021708592730400_ref2","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2460\/javma.1988.193.06.706","article-title":"Epidemiologic, clinical, pathologic, and prognostic characteristics of splenic hemangiosarcoma and splenic hematoma in dogs: 217 cases (1985)","volume":"193","author":"Prymak","year":"1988","journal-title":"J Am Vet Med Assoc"},{"key":"2026021708592730400_ref3","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1177\/104063870401600606","article-title":"A retrospective study of visceral and nonvisceral haemangiosarcoma and hemangiomas in domestic animals","volume":"16","author":"Schultheiss","year":"2004","journal-title":"J Vet Diagn Invest"},{"key":"2026021708592730400_ref4","doi-asserted-by":"publisher","first-page":"370","DOI":"10.5326\/JAAHA-MS-5954","article-title":"VAC protocol for treatment of dogs with stage III hemangiosarcoma","volume":"49","author":"Alvarez","year":"2013","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026021708592730400_ref5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2460\/javma.1985.186.01.56","article-title":"Canine haemangiosarcoma: retrospective analysis of 104 cases","volume":"186","author":"Brown","year":"1985","journal-title":"J Am Vet Med Assoc"},{"key":"2026021708592730400_ref6","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/j.1748-5827.1988.tb01907.x","article-title":"Metastatic pattern in dogs with splenic haemangiosarcoma","volume":"29","author":"Waters","year":"1988","journal-title":"J Small Anim Pract"},{"key":"2026021708592730400_ref7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2460\/javma.247.4.393","article-title":"Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001-2012)","volume":"247","author":"Wendelburg","year":"2015","journal-title":"J Am Vet Med Assoc"},{"key":"2026021708592730400_ref8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.5326\/15473317-34-5-417","article-title":"Prognosis for dogs with stage I or II splenic hemangiosarcoma treated by splenectomy alone: 32 cases (1991\u20131993)","volume":"34","author":"Wood","year":"1998","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026021708592730400_ref9","volume-title":"TNM Classification of Tumours in Domestic Animals","author":"Owen","year":"1980","edition":"1st"},{"key":"2026021708592730400_ref10","first-page":"967","article-title":"Canine visceral hemangiosarcoma treated with surgery alone or surgery and doxorubicin: 37 cases (2005-2014)","volume":"59","author":"Batschinski","year":"2018","journal-title":"Can Vet J"},{"key":"2026021708592730400_ref11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/vco.12548","article-title":"Retrospective comparison of first-line adjuvant anthracycline vs metronomic-based chemotherapy protocols in the treatment of stage I and II canine splenic haemangiosarcoma","volume":"18","author":"Treggiari","year":"2020","journal-title":"Vet Comp Oncol"},{"key":"2026021708592730400_ref12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.5326\/JAAHA-MS-5525","article-title":"Treatment with DAV for advanced-stage hemangiosarcoma in dogs","volume":"47","author":"Dervisis","year":"2011","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026021708592730400_ref13","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.2460\/javma.231.10.1550","article-title":"Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997\u20132004)","volume":"231","author":"Kim","year":"2007","journal-title":"J Am Vet Med Assoc"},{"key":"2026021708592730400_ref14","doi-asserted-by":"publisher","first-page":"304","DOI":"10.5326\/JAAHA-MS-6540","article-title":"Adjuvant doxorubicin with or without metronomic cyclophosphamide for canine splenic hemangiosarcoma","volume":"53","author":"Matsuyama","year":"2017","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026021708592730400_ref15","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1892\/0891-6640(2000)014&lt;0395:chtwsc&gt;2.3.co;2","article-title":"Canine hemangiosarcoma treated with standard chemotherapy and minocycline","volume":"14","author":"Sorenmo","year":"2000","journal-title":"J Vet Intern Med"},{"key":"2026021708592730400_ref16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1892\/0891-6640(2004)18&lt;209:eatoad&gt;2.0.co;2","article-title":"Efficacy and toxicity of a dose-intensified doxorubicin protocol in canine hemangiosarcoma","volume":"18","author":"Sorenmo","year":"2004","journal-title":"J Vet Intern Med"},{"key":"2026021708592730400_ref17","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1177\/03009858231225507","article-title":"Prognostic impact of ki-67 in canine splenic hemangiosarcoma: a preliminary study","volume":"61","author":"Brigand\u00ec","year":"2024","journal-title":"Vet Pathol"},{"key":"2026021708592730400_ref18","doi-asserted-by":"publisher","first-page":"630","DOI":"10.2460\/javma.258.6.630","article-title":"Retrospective evaluation of thrombocytopenia and tumor stage as prognostic indicators in dogs with splenic hemangiosarcoma","volume":"258","author":"Masyr","year":"2021","journal-title":"J Am Vet Med Assoc"},{"key":"2026021708592730400_ref19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2460\/javma.251.5.559","article-title":"Evaluation of clinical and histologic factors associated with survival time in dogs with stage II splenic hemangiosarcoma treated by splenectomy and adjuvant chemotherapy: 30 cases (2011\u20132014)","volume":"251","author":"Moore","year":"2017","journal-title":"J Am Vet Med Assoc"},{"key":"2026021708592730400_ref20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1939-1676.1991.tb00943.x","article-title":"Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma","volume":"5","author":"Hammer","year":"1991","journal-title":"J Vet Intern Med"},{"key":"2026021708592730400_ref21","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.2460\/javma.1989.195.11.1580","article-title":"Phase II evaluation of doxorubicin for treatment of various canine neoplasms","volume":"195","author":"Ogilvie","year":"1989","journal-title":"J Am Vet Med Assoc"},{"key":"2026021708592730400_ref22","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1892\/0891-6640(2007)21[764:clocfa]2.0.co;2","article-title":"Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs","volume":"21","author":"Lana","year":"2007","journal-title":"J Vet Intern Med"},{"key":"2026021708592730400_ref23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/vco.12519","article-title":"Adjuvant anthracycline-based vs metronomic chemotherapy vs no medical treatment for dogs with metastatic splenic hemangiosarcoma: a multi-institutional retrospective study of the Italian Society of Veterinary Oncology","volume":"17","author":"Marconato","year":"2019","journal-title":"Vet Comp Oncol"},{"key":"2026021708592730400_ref24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/jsap.12926","article-title":"The addition of metronomic chemotherapy does not improve outcome for canine splenic haemangiosarcoma","volume":"60","author":"Alexander","year":"2019","journal-title":"J Small Anim Pract"},{"key":"2026021708592730400_ref25","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/jvim.15456","article-title":"Prevalence, distribution, and clinical characteristics of hemangiosarcoma-associated skeletal muscle metastases in 61 dogs: a whole body computed tomographic study","volume":"33","author":"Carloni","year":"2019","journal-title":"J Vet Intern Med"},{"key":"2026021708592730400_ref26","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/vru.12723","article-title":"Prevalence of pulmonary nodules in dogs with malignant neoplasia as determined by CT","volume":"60","author":"Lamb","year":"2019","journal-title":"Vet Radiol Ultrasound"},{"key":"2026021708592730400_ref27","volume-title":"Ettinger's Textbook of Veterinary Internal Medicine","author":"Ettinger","year":"2024"},{"key":"2026021708592730400_ref28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/vco.283","article-title":"Veterinary cooperative oncology group common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.1","volume":"14","year":"2016","journal-title":"Vet Comp Oncol"},{"key":"2026021708592730400_ref29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/vco.12032","article-title":"Response evaluation criteria for solid tumours in dogs (v1.0): a veterinary cooperative oncology group (VCOG) consensus document. Vet comp","volume":"13","author":"Nguyen","year":"2015","journal-title":"Oncol"},{"key":"2026021708592730400_ref30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0306-9877(80)90079-1","article-title":"Possible reasons for the high resistance of muscle to cancer","volume":"6","author":"Seely","year":"1980","journal-title":"Med Hypotheses"},{"key":"2026021708592730400_ref31","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/vco.12925","article-title":"Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma","volume":"21","author":"Estabrooks","year":"2023","journal-title":"Vet Comp Oncol"},{"key":"2026021708592730400_ref32","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/vco.12927","article-title":"Patterns of metastatic progression and association with clinical outcomes in canine osteosarcoma: a necropsy study of 83 dogs","volume":"21","author":"Silver","year":"2023","journal-title":"Vet Comp Oncol"},{"key":"2026021708592730400_ref33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/jsap.12796","article-title":"Does thalidomide prolong survival in dogs with splenic haemangiosarcoma?","volume":"59","author":"Bray","year":"2018","journal-title":"J Small Anim Pract"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/40\/1\/aalag027\/66958483\/aalag027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/40\/1\/aalag027\/66958483\/aalag027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T13:59:35Z","timestamp":1771336775000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/doi\/10.1093\/jvimsj\/aalag027\/8488660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,21]]}},"URL":"https:\/\/doi.org\/10.1093\/jvimsj\/aalag027","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1]]},"article-number":"aalag027"}}